Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,784 | -137,464 | -110,014 | -89,868 | -26,424 |
| Depreciation Amortization | 588 | 1,493 | 907 | 506 | 259 |
| Income taxes - deferred | N/A | 26,025 | 25,916 | 25,870 | -4,323 |
| Accounts payable and accrued liabilities | 468 | -3,108 | -11,629 | -4,457 | -5,613 |
| Other Working Capital | -3,431 | 24,535 | 17,514 | 8,759 | -7,043 |
| Other Operating Activity | 2,926 | 18,215 | 22,368 | 11,055 | 9,099 |
| Operating Cash Flow | $-30,233 | $-70,304 | $-54,938 | $-48,135 | $-34,045 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,066 | 80,414 | 57,539 | 54,299 | 42,251 |
| PPE Investments | N/A | -716 | -716 | N/A | N/A |
| Investing Cash Flow | $5,066 | $79,698 | $56,823 | $54,299 | $42,251 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,942 | 28,000 | 12,724 | 2,009 | 2,009 |
| Other Financing Activity | 22,500 | -13,457 | -4,803 | -4,803 | 0 |
| Financing Cash Flow | $34,442 | $14,543 | $7,921 | $-2,794 | $2,009 |
| Exchange Rate Effect | 135 | -664 | 201 | 50 | -50 |
| Beginning Cash Position | 73,981 | 50,708 | 50,708 | 50,708 | 50,708 |
| End Cash Position | 83,391 | 73,981 | 60,715 | 54,128 | 60,873 |
| Net Cash Flow | $9,410 | $23,273 | $10,007 | $3,420 | $10,165 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,233 | -70,304 | -54,938 | -48,135 | -34,045 |
| Capital Expenditure | N/A | -716 | -716 | N/A | N/A |
| Free Cash Flow | -30,233 | -71,020 | -55,654 | -48,135 | -34,045 |